Characterization of head and neck lesions with diffusion-weighted MR imaging and the apparent diffusion coefficient values  by El Shahat, Hazem M. et al.
OC with
d parent
d
H r *
De
Re
Av
ine the role of diffusion-weighted MR
C) in characterization of head and neck
eighted sequences was performed on 43
obtained with a diffusion-weighted fac-
re reconstructed, and the ADC value of
.02 ± 0.22) · 103 mm2/s (n= 31). The
03 mm2/s (n= 12). The mean ADC of
mas. The difference in the ADC value
stically signiﬁcant (p< 0.001). Selection
differentiating benign from malignant
sitivity of 95%, speciﬁcity of 92%, posi-
of 94%.
ing, non-invasive imaging approach that
t can help differentiate malignant tumors
gyptian Society of Radiology and Nuclear
* C
E-m
com
Pee
Nu
The Egyptian Journal of Radiology and Nuclear Medicine (2013) 44, 791–798
edicine
rMedicine
037
OpeRIGINAL ARTICLE
haracterization of head and neck lesions
iﬀusion-weighted MR imaging and the ap
iﬀusion coeﬃcient values
azem M. El Shahat, Hadeer S. Fahmy, Ghada K. Gouha
partment of Radiology, Faculty of Medicine, Zagazig University, Egypt
ceived 13 July 2013; accepted 25 August 2013
ailable online 18 September 2013
KEYWORDS
DWI;
Head and neck
Abstract Purpose: The aim of this study was to determ
imaging (DWI) and the apparent diffusion coefﬁcient (AD
lesions.
Patients and methods: MR imaging including diffusion-w
patients presented with head and neck lesions. Images were
tor (b factor) of 100, 500, and 1000 s/mm2. ADC maps we
the lesions was calculated.
Results: The mean ADC value of malignant tumors was (1
mean ADC value of benign tumors was (1.62 ± 0.27) · 1
lymphomas was signiﬁcantly lower than that of carcino
between the malignant tumors and benign lesions was stati
of (1.2) · 103 mm2/s as a threshold value of ADC for
tumors yielded the best result, with an accuracy of 94%, sen
tive predictive value of 92% and negative predictive value
Conclusion: DWI and the ADC measurement are promis
can be used for characterization of head and neck lesions. I
from benign lesions.
 2013 Production and hosting by Elsevier B.V. on behalf of E
Egyptian Society of Radiology and Nuclear M
The Egyptian Journal of Radiology andNuclea
www.elsevier.com/locate/ejrnm
www.sciencedirect.comMedicine.
1. Introduction
In spite of early enthusiasm, MR imaging did not have the last
word in histological speciﬁcity and did not eliminate the need
for biopsies or aspirations of the lesions. Spin echo imaging is
still the mainstay of MR imaging, but now various new tech-
niques hold promise for the future of head and neck imaging.
Diffusion-weighted imaging (DWI) with magnetic resonance
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relies upon the relative diffusivity of water protons within the
tissue. This technique is based on the amount of random
(Brownian) motion that water protons undergo. This tech-
nique has proven quite useful for brain imaging in differentiat-
ing between infarcted tissue and other pathological processes
(1). The potential utility of DWI for evaluating extracranial
neoplastic disease is only recently recognized (2).
Diffusion-weighted images are obtained by applying pairs
of opposing magnetic ﬁeld gradients around the refocusing
pulse of a T2*-weighted sequence. Water molecules will be de-
phased by the ﬁrst gradient and rephased by the second gradi-
ent. If the water molecules are stationary, no net dephasing is
expected. Movement of the tissue water molecules between the
two opposing gradients will result in dephasing, depicted as
signal loss on the diffusion-weighted images. Some intrinsic
T2-weighted information, however, is contained in such
images. Thus arithmetic processing is performed between the
sets to generate apparent diffusion coefﬁcient (ADC) maps,
eliminating contributions from T2 signal changes (3).
The signal loss in diffusion-weighted images will be propor-
tional to the amount of water molecule movement and the
strength of the gradients (b-value). By repeating the sequence
with different b-values, the observed signal loss can be quanti-
ﬁed using the ADC (4).
In normal tissue or in areas exhibiting vasogenic edema, the
motion of water molecules is not limited and no restricted dif-
fusion should be noted. In tissues with cytotoxic edema or in
highly cellular regions, however, there is a diffusion restriction,
which can be measured both qualitatively and quantitatively
(5).
Hypercellular tissue, as occurring within malignant tumors,
will show low ADC values. Non-tumoral tissue changes such
as edema, inﬂammation, ﬁbrosis and necrosis are expected to
show low cellularity, in strong contrast with viable tumor. This
results in high ADC values. An inverse correlation between the
ADC value and tumor cellularity in experimental models has
been shown, and this was clinically validated (6,7).
In the head and neck region, DWI may have several possi-
ble applications. DWI has demonstrated usefulness to discrim-
inate speciﬁc histological tumor types, especially to
differentiate benign solid lesions from malignant masses.
DWI may be of particular value in characterization of neck
lymph nodes. Differentiation of post-treatment tissue changes
and persistent or recurrent cancer is another topic in which
DWI may be very helpful. The inﬂammatory or post-treatment
tissue does not demonstrate restricted diffusion, likely due to a
relatively low cellularity. Recurrent or residual disease, how-
ever, contains regions of increased cellularity and thus should
demonstrate restricted diffusion. Furthermore, DWI can also
be used as a whole body imaging at high b-values with ADC
mapping to exclude or conﬁrm metastatic disease or a second
primary tumor. Moreover, DWI seems to be a safer and more
affordable method considering the absence of radiation and to
the higher cost of FDG-PET/CT (8–11).
Technical standarization, however, is still not achieved; re-
sults obtained depend on selection of b-values. Magnetic ﬁeld
inhomogeneity and suboptimal placement of receiver coils can
have a negative impact on image quality. Interpretation of
DWI in the head and neck requires training and experience (4).
The purpose of our study was to evaluate the role of DWI
and ADC measurement in initial characterization of head and
neck lesions.
2. Patients and methods
The study involved 43 patients (25 male, 18 female; age range
21–72 years). The inclusion criteria were patients with un-
treated head and neck lesions. Informed consent was taken
from all patients. MR imaging was performed on a 1.5-T
MR unit (GE, Signa Exite). All patients underwent non-en-
hanced T1-weighted (T1-W), fat-suppressed T2-weighted
(T2-W), and gadolinium-enhanced fat-suppressed T1-weighted
images. Diffusion-weighted MR images were obtained using a
multislice single-shot spin-echo echo-planar sequence. Diffu-
sion-Weighted MR images were acquired with a b-factor of
100, 500 and 1000 s/mm2, and ADC maps were generated.
Quantitative analysis of the ADC map was made. A region
of interest (ROI) was drawn using an electronic cursor around
the margin of the solid portion of the mass, taking care to
avoid the cystic parts. The ﬁnal diagnosis was made by endos-
copy-guided biopsy in 27 patients or by histopathological
examination after surgery in 16 patients. Statistical analysis
was done using Excel and SPSS (Statistical Package for Social
Science version 10). Data were described as mean + standard
deviation (SD). Data were analyzed to test statistically signiﬁ-
cant differences. To compare between two groups, Student’s t
test was applied. Receiver operating characteristic (ROC)
curves were generated to determine the cutoff value, to evalu-
ate the diagnostic capability of the ADC value for use in the
differentiation between malignant and benign lesions and in
the differentiation between lymphoma and carcinoma.
3. Results
The ﬁnal diagnosis of the lesions is listed in Table 1. The mean
ADC value of malignant lymphomas was (0.64 ± 0.16) · 103
Table 1 Diagnosis of head and neck lesions.
Diagnosis No. of lesions
Malignant (n = 31)
Lymphoma 12
Squamous cell carcinoma (nasopharynx) 4
Squamous cell carcinoma (oropharynx) 3
Squamous cell carcinoma (palatine tonsil) 2
Squamous cell carcinoma (larynx) 6
Adenoid cystic carcinoma (parotid) 2
Chordoma 2
Benign (n = 12)
Pleomorphic adenoma (parotid) 8
Inﬂammatory lesion (occipital) 1
Schwannoma (jugular foramen) 1
Meningioma (cavernous sinus) 2
Table 2 Mean ADC values of malignant tumors and benign
lesions.
Diagnosis Mean ADC values
Malignant (n= 31)
Lymphomas (n= 12) (0.64 ± 0.16) · 103 mm2/s
Carcinomas (n= 17) (1.02 ± 0.22) · 103 mm2/s
Chordomas (n= 2) (0.96 ± 0.14) · 103 mm2/s
Benign (n= 12) (1.62 ± 0.27) · 103 mm2/s
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mm2/s. The mean ADC value of carcinomas was
(1.02 ±0.22) · 103 mm2/s. The mean ADC value of benign tu-
mors was (1.62 ± 0.27) · 103 mm2/s. There was a statistically
signiﬁcant difference in ADC values between malignant and be-
nign tumors (p< 0.001). Table 2 shows mean ADC values of
malignant tumors and benign lesions. Cases are presented in
Figs. 1–5.
ROC curve analysis revealed that the threshold ADC value
(1.2) · 103 mm2/s used for differentiating between benign and
malignant head and neck lesions had an accuracy of 94%, sen-
sitivity of 95%, speciﬁcity of 92%, positive predictive value of
92% and negative predictive value of 94%.
4. Discussion
Head and neck cancers account for the sixth most common
type of cancer worldwide, with betel, tobacco and alcohol con-
sumption being important risk factors causing signiﬁcant mor-
bidity and mortality. Squamous cell carcinoma (SCC) is the
most common malignant histology in the head and neck region
and originates from the epithelial lining of the upper aerodiges-
tive tract. Approximately two-thirds of patients with head and
neck cancers present with advanced stage disease, commonly
involving regional lymph nodes, which require an ampliﬁed
Fig. 1 Malignant lymphoma. (A) Axial T2-weighted fat-suppression spin-echo MR image shows multiple bilateral jugular and spinal
accessory chains enlarged cervical lymph nodes. (B) Axial diffusion-weighted echo-planar MR image at b factor of 1000 s/mm2, shows
high signal intensity of the enlarged lymph nodes. (C) Apparent diffusion coefﬁcient (ADC) map shows low signal intensity of the lymph
nodes with low ADC value (0.62 · 103 mm2/s). (D) Axial T2-weighted fat-suppression spin-echo MR image, in another patient shows
enlarged left-sided submandibular lymph node. (E) Axial diffusion-weighted echo-planar MR image at b factor of 1000 s/mm2, shows high
signal intensity of the enlarged lymph node. (F) Apparent diffusion coefﬁcient (ADC) map shows low signal intensity of the lymph node
with low ADC value (0.61 · 103 mm2/s).
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and aggressive treatment regimen consisting of neoadjuvant
therapy and extensive surgery (12–14).
Differentiation of malignant head and neck tumors from be-
nign lesions and accurate deﬁnite diagnosis are essential for
treatment planning as well as for prognosis of malignant tu-
mors. A variety of imaging techniques can help in characteriza-
tion of head and neck masses. Ultrasound has a role in cystic
lesions but it cannot determine the nature of solid masses. Con-
ventional CT and MRI continue to be the primary imaging
modalities for evaluating head and neck cancers. However, both
of these modalities rely on volumetric and morphological crite-
ria and consequently suffer from low sensitivity and accuracy
when making the diagnosis (15). Moreover, post-treatment
changes can be difﬁcult to separate from tumor recurrence, as
both entities may present with similar imaging features.
AdvancedMR imaging techniques provide information regard-
ing the metabolic, molecular and pathophysiological aspects of
a tumor. These techniques include the use of proton and
phosphorous MR spectroscopy, dynamic contrast-enhanced
MR imaging and diffusion-weighted imaging in initial diagnos-
tic characterization of head and neck cancers (14). The potential
of FDG-PET/CT in evaluating SCC of the head and neck have
demonstrated in numerous studies. Since FDG ([18F]-ﬂuoro-2-
deoxy-glucose) uptake is not speciﬁc to cancer, false positive
ﬁndings, owing to inﬂammatory processes andmetabolically ac-
tive regions are common (16). Biopsy is commonly used, but it is
invasive and may give false results (4,5,17).
Diffusion-weighted echo-planar MR imaging is a technique
for evaluation of the rate of microscopic random water diffu-
sion in tissues. The extent of translational diffusion of mole-
cules measured in the human body is referred to as the
ADC. The ADC is expected to vary according to the cellular
density of the lesion (18).
The aim of this study was to evaluate the role of DWI and
ADC measurement in the characterization of head and neck
lesions.
Fig. 2 Nasopharyngeal carcinoma. (A) Axial T2-weighted fat-suppression spin-echo MR image shows mass lesion obliterating the fossa
of Rosenmuller at the left side. (B) Axial gadolinium-enhanced T1-weighted spin-echo MR image shows moderate enhancement of the
mass. (C) Axial diffusion-weighted echo-planar MR image at b factor of 1000 s/mm2, the lesion appears hyperintense, indicating diffusion
restriction. (D) Apparent diffusion coefﬁcient (ADC) map shows low signal intensity of the mass with low ADC value (0.74 · 103 mm2/s).
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A study proposed by Wang et al. (19), aiming at character-
ization of head and neck masses by diffusion-weighted
echo-planar MR imaging, found that the mean ADC value
of benign solid tumors was higher than malignant tumors.
Eida et al. (20) studied ADC mapping of salivary gland
tumors and concluded that ADC can provide preoperative
tissue characterization of salivary gland tumors. Abdel Razek
et al. (21) found that in malignant thyroid, nodules show a
signiﬁcantly lower ADC value than that of benign solitary
thyroid nodules. White et al. (22) found a statistically signif-
icant difference in ADC values between benign and malig-
nant lesions involving the paranasal sinuses and skull base.
Abdel Razek et al. (23) added that the mean ADC value of
nasal and paranasal sinus malignant lesions is signiﬁcantly
different from that of benign lesions. Sumi et al. (24) stated
that the ADC value is a helpful parameter in discriminating
metastatic nodes in the neck. Abdel Razek et al. (25) found
that the ADC map is a new technique that can help in differ-
entiation of non-necrotic malignant from benign lymph
nodes.
In our study, the mean ADC value of malignant head and
neck tumors was signiﬁcantly lower than that of benign le-
sions, in agreement with the previously mentioned studies.
This is explained by the difference in histopathologic features
of the benign and malignant tumors. Malignant tumors have
enlarged nuclei, hyperchromatism and angulation of nuclear
contour, and they show hypercellularity. These histological
characteristics reduce the extracellular matrix and the diffu-
sion space of water protons in the extracellular and intracel-
lular dimensions with a resultant decrease in ADC values
(14,26).
Sumi et al. (27) and Maeda et al. (28) reported that squa-
mous cell carcinoma has a higher ADC value than lymphoma
because carcinoma may contain small foci of necrosis on histo-
pathological examination that are not identiﬁable on MR
images. Sumi et al. (29) reported that the mean ADC value
of lymphomas is also lower than metastatic lymph nodes due
to the difference in cellularity.
In our study, we have similar results as the mean ADC va-
lue of carcinomas was signiﬁcantly higher than that of malig-
nant lymphomas.
Although we found signiﬁcant differences in ADC values
between benign and malignant lesions, there was variability
in ADC values within each group. This could be because of
the difference in internal architecture between lesions (30).
This was in agreement with Hamphries et al. (31) and Abdel
Razek et al. (32).
Limitations in our study include unavoidable image distor-
tion to some degree and therefore, the ADC values measured
in small lesions might be inaccurate. Also, measuring the
Fig. 3 Laryngeal glottic carcinoma. (A) Axial T2-weighted fat-suppression spin-echo MR image shows left-sided tumor mass centered
on the true vocal cord, involving the anterior commissure crossing to the other side. (B) Axial gadolinium-enhanced T1-weighted spin-
echo MR image shows enhancement of the lesion. (C) Axial diffusion-weighted echo-planar MR image at b factor of 1000 s/mm2, the
lesion appears hyperintense, indicating diffusion restriction. (D) Apparent diffusion coefﬁcient (ADC) map shows low signal intensity of
the mass with low ADC value (0.72 · 103 mm2/s).
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ADC values of the lesions located adjacent to the air-contain-
ing organs is not accurate because of susceptibility artifacts.
Diffusion-weighted MR imaging using echo-planar imag-
ing (EPI) has best results owing to its speed and a lower mo-
tion artifact. Diffusion-weighted echo-planar pulse sequence
is the sequence of choice for the quantitative study of diffu-
sion, because the diffusion and relaxation effects contribute
separately to the MR signal intensity and can be easily
separated; furthermore, EPI is a very fast technique that
enables data acquisition, with different b values within a
Fig. 4 Chordoma. (A) Sagittal T1-weighted spin-echo MR image shows intermediate signal intensity mass centered on the clivus. (B)
Axial T2-weighted spin-echo MR image shows the clival lesion. (C) Axial gadolinium-enhanced T1-weighted spin-echo MR image shows
moderate enhancement of the lesion. (D) Axial diffusion-weighted echo-planar MR image at b factor of 1000 s/mm2, shows high signal
intensity of the lesion. (E) Apparent diffusion coefﬁcient (ADC) map shows low signal intensity of the mass with low ADC value
(0.92 · 103 mm2/s).
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reasonably short time. The main trade-off of the EPI pulse
sequence is that it is very sensitive to magnetic susceptibility
effects, resulting in geometric distortion artifacts that tend to
be more severe with increasing b values (19,21,33–35). How-
ever, newer techniques such as SPLICE, line scan DWI, fast
asymmetric spin-echo and BLADE (PROPELLER), are
being introduced in order to acquire better quality DWI data
(14).
In conclusion, diffusion-weighted MR imaging can help in
the characterization of head and neck lesions, and its ﬁndings
may provide useful information before surgery or biopsy.
Diffusion-weighted MR imaging could be included in the
routine MR imaging protocol to evaluate head and neck
cancers. Diffusion-weighted MR imaging provides comple-
mentary information for conventional structural MR imaging
techniques.
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